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Heparan sulfate proteoglycans are 
highly negatively charged molecules 
that have been thought to provide 
the negative charge in the glomerular 
basement membrane, which restricts 
protein passage through the basement 
membrane. However, a number of stud-
ies suggest that this critical negative 
charge is provided by other molecules, 
such as sialylated glycoproteins. In this 
issue, Chen et al. show that deletion in 
podocytes of the gene for Ext1, which 
encodes a subunit of heparan sulfate co-
polymerase, disables the polymerization 
of heparan sulfate glycosaminoglycans. 
When they examined the development 
of the glomerular basement membrane 
and podocytes in mice, the authors 
found that it was normal; however, foot 
process effacement was seen as early as 
one month after birth. Despite the loss 
of heparan sulfate glycosaminoglycans, 
no proteinuria developed. Although it 
appears that these proteoglycans are not 
necessary to restrict the permselectivity 
of the basement membrane, they seem to 
be important for podocyte morphology. 
See page 289.
CXCL16 is released 
by ADAM10 during 
tubulointerstitial 
inflammation
The chemokine CXCL16 has been 
shown to recruit leukocytes to sites 
of inflammation in several models 
of glomerulonephritis. Schramme et 
al. now show that this chemokine is 
expressed by the distal tubule, con-
necting tubule, and principal cells of 
the collecting duct. Closer examination 
showed that CXCL16 was expressed as 
both membrane-associated and secreted 
forms. The generation of secreted 
forms appeared to be due to actions 
of the disintegrin-like metalloprotein-
ase ADAM10, which is present in the 
same nephrin segments that express 
CXCL16. Renal allograft biopsies, with 
a histopathological diagnosis of acute 
interstitial rejection, showed increased 
basolateral ADAM10 expression and 
high numbers of infiltrating T cells. 
These studies demonstrate a new mecha-
nism for tubulointerstitial inflammation 
in transplant rejection. See page 328.
Loss of kidney 
function from  
oral estrogen use
Although women are generally protected 
from age-dependent loss of kidney func-
tion, the onset of menopause reduces this 
advantage. Ahmed et al. confirmed this 
hypothesis by studying a large cohort 
of older women, some of whom were 
taking oral estrogen. At the two-year 
follow-up, the authors found a remark-
able association between hormone use 
and increased serum creatinine. This 
loss of estimated GFR was associated 
with oral but not transvaginal estrogen 
use. See page 370.
